Abstract
Background
The purpose of this study was to evaluate the influence of previous argon laser trabeculoplasty (ALT) on transforming growth factor-beta 2 (TGF-beta 2) concentration of the aqueous humor and its influence on bleb scarring after trabeculectomy.
Methods
Fifty-one patients with primary open-angle glaucoma (POAG) and 29 patients with exfoliation (XFS) glaucoma were recruited for this prospective study before undergoing trabeculectomy. Sixty to 200 µl of aqueous humor were analyzed for total and biologically active TGF-beta 2 concentrations (R and D Systems). TGF-beta 2 levels and a standardized bleb assessment were compared between the ALT- and non-ALT-treated groups.
Results
POAG eyes without ALT showed significantly higher total TGF-beta 2 levels (2,317.7±1,041.1 pg/ml) than eyes with previous ALT (1,621.6±899.6 pg/ml; P=0.026). No significant difference was found for active TGF-beta 2 levels (ALT: 238.1±119.0 pg/ml; no ALT: 220.1±96.9 pg/ml; P=0.585). In XFS patients ALT did not alter total TGF-beta 2 levels (ALT: 1,524.9±624.9 pg/ml, no ALT: 1,220±499.1 pg/ml; P=0.20), but active TGF-beta 2 was significantly higher in the ALT-treated (237.0±99.7 pg/ml) than in the non-ALT-treated (140.0±95.3 pg/ml, P=0.028) group. Bleb grading revealed no statistical difference between the ALT- and non-ALT-treated groups in POAG (P=0.545, Fisher's exact test), whereas XFS patients with ALT were at increased risk for scarring compared to non-ALT-treated patients (P=0.053).
Conclusions
ALT appears to increase the risk of scarring in XFS patients because of increased levels of activated TGF-beta 2.
Similar content being viewed by others
References
Feller DB, Weinreb RN (1984) Breakdown and reestablishment of blood-aqueous barrier with laser trabeculoplasty. Arch Ophthalmol 102:537–538
Fiore PM, Melamed S, Epstein DL (1989) Trabecular precipitates and elevated intraocular pressure following argon laser trabeculoplasty. Ophthalmic Surg 20:697–701
Grinich NP, Van Burskirk EM, Samples JR (1987) Three-year efficacy of argon laser trabeculoplasty. Ophthalmology 94:858–861
Heckmann M, Aumailley M, Chu M, Timpl R, Krieg T (1991) Effect of transforming growth factor-b on collagen type VI expression in human dermal fibroblasts FEBS 310:79–82
Higginbotham EJ, Richardson TM (1986) Response of exfoliation glaucoma to laser trabeculoplasty. Br J Ophthalmol 70:837–839
Inatani M, Tanihara H, Katsuta H, Honjo M, Kido N, Honda Y (2001) Transforming growth factor-b2 levels in aqueous humor of glaucomatous eyes. Graefes Arch Clin Exp Ophtahlmol 239:109–113
Jampel HD, Roche N, Stark WJ, Roberts AB (1990) Transforming growth factor-beta in human aqueous humor. Curr Eye Res 9:963–969
Khalil N (1999) TGF-beta: from latent to active. Microbes Infect 1: 1255–1263
Koliakos GG, Schloetzer-Schrehardt U, Konstas AGP, Bufidis T, Georgiadis N, Dimitriadou A (2001) Transforming and insulin-like growth factors in the aqueous humor of patients with exfoliation syndrome. Graefes Arch Clin Exp Ophtalmol 239:482–487
Kuechle M, Vinores SA, Mahlow J, Green WR (1996) Blood-aqueous barrier in pseudoexfoliation syndrome: evaluation by immunohistochemical staining of endogenous albumin. Graefes Arch Clin Exp Ophthalmol 234:12–18
Madri J, Pratt BM, Tucker AM (1988) Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol 106:1375–1384
Melamed S, Pei J, Epstein DL (1985) Short-term effect of argon laser trabeculoplasty in monkeys. Arch Ophthalmol 103:1546–1552
Nguyen NX, Kuechle M, Martus P, Naumann GO (1999) Quantification of blood-aqueous barrier breakdown after trabeculectomy: pseudoexfoliation versus primary open-angle glaucoma. J Glaucoma 8:18–23
Ogata N, Ando A, Uyama M, Matsumura M (2001) Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol 239:87–95
Pasquale LR, Dorman Pease ME, Lutty GA, Quigley HA, Jampel HD (1993) Immunolocalisation of TGF-b1, TGF-b2 and TGF-b3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci 34:23–30
Picht G, Grehn F (1998) Classification of filtering blebs in trabeculectomy: biomicroscopy and functionality. Curr Opin Ophthalmol 9:2–8
Picht G, Welge-Luessen U, Grehn F, Luetjen-Drecoll E (2001) Transforming growth factor-beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol 239:199–207
Pohjanpelto P (1983) Late results of laser trabeculoplasty for increased intraocular pressure. Acta Ophthalmol 61:998–1008
Reiss GR, Wilensky JT, Higginbotham EJ (1991) Laser trabeculoplasty. Major review. Surv Ophthalmol 35:407–428
Ritch, R, Schloetzer-Schrehardt U (2001) Exfoliation syndrome survey. Ophthalmology 45:265–315
Roberts AB, Sporn MB (1993) Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 8:1–9
Spaeth GL, Baez KA (1992) Argon laser trabeculoplasty controls one third of cases of progressive, uncontrolled, open angle glaucoma for 5 years. Arch Ophthalmol 110:491–494
Tamm ER, Siegner A, Baur A, Luetjen-Drecoll E (1996) Transforming growth factor-beta 1 induces alpha-smooth muscle-actin expression in cultured human and monkey trabecular meshwork. Exp Eye Res 62:389–397
The Advanced Glaucoma Intervention Study (AGIS) 4 (1998) Comparison of treatment outcomes within race. Ophthalmology 105/7:1146–1164
The Glaucoma Laser Trial Research Group (1990) Results of ALT versus topical medications. Ophthalmology 97:1403–1413
Tripathi RC (1994) Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res 59:723–727
Tripathi RC, Chan WF, Li J, Tripathi BJ (1994) Trabecular cells express the TGF-beta 2 gene and secrete the cytokine. Exp Eye Res 58:523–528
Unger WG, Cole DF, Bass MS (1977) Prostaglandins and neurologically mediated ocular response to laser irradiation of the rabbit iris. Exp Eye Res 25:209–220
Varga J, Rosenbloom J, Jimenez SA (1987) Transforming growth factor beta (TGF beta) causes a persistent increase in steady state amounts of type I and type III collagen and fibronectin MRNAs in normal human dermal fibroblasts. Biochem J 247:597–604
Welge-Lüßen U, May CA, Lütjen-Drecoll E (2000) Induction of tissue transglutaminase in the trabecular meshwork by TGF-ß1 and TGF-ß2. IOVS 41:2229–2238
Acknowledgements
We thank the Department of Neurology, Wuerzburg (Dr. P.Rieckmann, B. Meyer), for laboratory assistance and Dr. W. Sabisch for assistance with statistics.
Author information
Authors and Affiliations
Corresponding author
Additional information
All human studies have been reviewed by the Ethics Committee of the University of Wuerzburg and have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. All persons gave their informed consent prior to their inclusion in the study. The manuscript will not be published elsewhere in any language without the consent of the copyright holders, the right of third parties will not be violated and the publisher will not be held legally responsible should there be any claims for compensation.
Rights and permissions
About this article
Cite this article
Wimmer, I., Welge-Luessen, U., Picht, G. et al. Influence of argon laser trabeculoplasty on transforming growth factor-beta 2 concentration and bleb scarring following trabeculectomy. Graefe's Arch Clin Exp Ophthalmol 241, 631–636 (2003). https://doi.org/10.1007/s00417-003-0721-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-003-0721-x